edetic acid has been researched along with sirolimus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bradley, JA; Bradley, JR; Chaudhry, A; Firth, J; Palmer, CR; Pritchard, N; Smith, JC; Watson, CJ; Williams, PF | 1 |
| Fägerlind, M; Friman, S; Friman, V; Gäbel, M; Herlenius, G; Krantz, M; Mölne, J; Olausson, M; Oltean, M | 1 |
| Bergeron, A; Bergeron, M; Furtado, M; Garofolo, F | 1 |
1 review(s) available for edetic acid and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for edetic acid and sirolimus
| Article | Year |
|---|---|
A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation.
Topics: Adult; Aged; Blood Pressure; Calcineurin Inhibitors; Chromium Radioisotopes; Edetic Acid; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immune Tolerance; Immunosuppression Therapy; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Random Allocation; Research Design; Sirolimus; Time Factors; Treatment Outcome | 2005 |
Chronic kidney disease--a common and serious complication after intestinal transplantation.
Topics: Adult; Aged; Anti-Infective Agents; Child, Preschool; Chromium Radioisotopes; Chronic Disease; Digestive System Surgical Procedures; Disease Progression; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Intestines; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Reoperation; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome | 2008 |
1 other study(ies) available for edetic acid and sirolimus
| Article | Year |
|---|---|
Impact of plasma and whole-blood anticoagulant counter ion choice on drug stability and matrix effects during bioanalysis.
Topics: Anticoagulants; Chromatography, Reverse-Phase; Drug Stability; Edetic Acid; Fluconazole; Granisetron; Heparin; Humans; Hydrogen-Ion Concentration; Ions; Limit of Detection; Pharmaceutical Preparations; Sirolimus; Spectrometry, Mass, Electrospray Ionization | 2009 |